Personalis, Inc.
NASDAQ:PSNLMedical - Diagnostics & Research
+$0.34 today
- Market cap
- $1.62B
- Beta
- 2.28
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$0.92
Volume 1.47M
Average 2.31M
PSNL Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Personalis, Inc.NASDAQ: PSNL
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q1 FY2026 depreciation & amortization of $2.37M fell 8.3% year over year, in line with the -8.1% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 3.7% from the prior quarter. Over 3 fiscal years it compounded at +6.0% a year.
Context
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -8.3% toward the trailing-twelve-month pace of -8.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 10.05M USD
- Year-over-year change
- -8.2%
- 4-year CAGR
- +13.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.05M | -8.2% |
| FY2024 | 2024-12-31 | 10.94M | -3.1% |
| FY2023 | 2023-12-31 | 11.3M | +34.0% |
| FY2022 | 2022-12-31 | 8.43M | +40.2% |
| FY2021 | 2021-12-31 | 6.01M | — |
Depreciation & Amortization vs competitors
How PSNL compares with its peers on the latest reported figures
- PSNL's LTM Mar 2026 depreciation & amortization of $9.83M is the smallest of the 10 companies compared; the peer median is $39.23M.
- Its year-over-year change of -8.1% is the 7th highest of 9, against a peer median of -1.7%.
- Depreciation & amortization amounts to 15.2% of revenue for PSNL, versus a peer median of 5.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $155.37M | -1.1% | +0.3% | 94.0% | |
| LTM Jun 2026 | $65.8M | +87.5% | +37.6% | 2.4% | |
| LTM Jun 2026 | $65.46M | -8.0% | -0.8% | 8.5% | |
| LTM Mar 2026 | $51.8M | -13.5% | +0.6% | 6.2% | |
| LTM Sep 2026 | $39.23M | -2.3% | +3.4% | 3.1% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | $26.88M | +15.1% | -24.8% | 5.9% |
| LTM Mar 2026 | $24.2M | +0.1% | -9.6% | 7.6% | |
| LTM Jun 2026 | $20.83M | -9.4% | -6.2% | 3.7% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $12.3M | — | — | 3.1% |
| LTM Mar 2026 | $9.83M | -8.1% | +6.0% | 15.2% | |
| Peer median (excluding PSNL) | $39.23M | -1.7% | -0.2% | 5.9% | |
Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (65.23M) | (113.32M) | (108.3M) | (81.28M) | (81.27M) |
| Depreciation & Amortization | 6.01M | 8.43M | 11.3M | 10.94M | 10.05M |
| Deferred Income Tax | 2.03M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 14.38M | 19.43M | 14.05M | 10.69M | 9.43M |
| Change in Working Capital | (31.14M) | 10.61M | 13.48M | (2.59M) | (10.19M) |
| Accounts Receivables | (12.12M) | 1.83M | (1.09M) | 9.59M | (8.06M) |
| Inventory | 29K | (2.98M) | (1.93M) | 4.43M | (204K) |
| Accounts Payables | (1.46M) | 3.09M | 5.18M | (8.92M) | 4.55M |
| Other Working Capital | (17.6M) | 8.68M | 11.33M | (7.68M) | (6.48M) |
| Other Non-Cash Items | 3.12M | 4.61M | 13.21M | 17.1M | (2.96M) |
| Operating Cash Flow | (70.83M) | (70.23M) | (56.26M) | (45.15M) | (74.95M) |
| Capital Expenditures | (11.08M) | (49.9M) | (10.91M) | (1.6M) | (4.5M) |
| Acquisitions (Net) | 48.99M | 0 | (24.01M) | 0 | 0 |
| Purchases of Investments | (267.13M) | (121.49M) | (103.95M) | (121.71M) | (210.17M) |
| Sales of Investments | 218.14M | 223.92M | 127.96M | 88M | 192.11M |
| Other Investing Activities | (48.99M) | 0 | 24.01M | 242K | 0 |
| Investing Cash Flow | (60.07M) | 52.54M | 13.1M | (35.07M) | (22.57M) |
| Debt Repayment | 3.31M | (1.1M) | 174K | (1.13M) | 585K |
| Common Stock Issued | 162.26M | 0 | 3.51M | 97.82M | 129.94M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 4.13M | 2.47M | 7.34M | 17.98M | (189K) |
| Financing Cash Flow | 169.7M | 1.37M | 11.03M | 114.67M | 130.34M |
| Effect of Forex Changes | 47K | (127K) | (16K) | (22K) | 6K |
| Net Change in Cash | 38.85M | (16.46M) | (32.14M) | 34.43M | 32.83M |
| Free Cash Flow | (81.91M) | (120.13M) | (67.17M) | (46.75M) | (79.45M) |
Personalis, Inc.
NASDAQ:PSNL
Intrinsic Alpha fair value
Locked
Current Price
$14.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.